IS:CAPLIPOINT Caplin Point Laboratories

Caplin Point Laboratories Limited produces, develops, markets, and exports generic formulations and branded products in India and internationally. It provides liquid injections, lyophilised injections, opthalmic products, liquid orals, capsules, tablets, softgel capsules, suppositories and ovules, dry syrups, topicals, inhalers, IV infusion products, dermo cosmetics, and other products, as well as powders for injection. The company was founded in 1990 and is headquartered in Chennai, India.

789.40 INR
As of 01/24/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  06/23/2014
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   59,838,480,384 INR
Current dividend yield:   0.38%
Sedol:      BYNJC27

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy